Table 2.
Surgical Data and Details for Patients Treated With Cervical Metastatic Disease.
| Characteristic | Surgery ± Radiation (N = 38) |
|---|---|
| Approach, n (%) | |
| Anterior | 9 (23.7) |
| Posterior | 23 (60.5) |
| Combined anterior/posterior | 6 (15.8) |
| Surgical levels, median (range) | 4.0 (1-8) |
| Surgical time, min, mean (SD) | 236.5 (109.8) |
| Length of stay, days, median (range) | 8.0 (2-26) |
| Previous radiation therapy, n (%) | 8 (21.1) |
| Adjuvant radiation therapy, n (%) | 11 (28.9) |
| Start of adjuvant radiotherapy, months, mean (SD) | 1.5 (1.0) |
| Intraoperative adverse event, n (%) | 4 (10.5) |
| Dural tear | 1 (2.6) |
| Implant complication requiring revision | 1 (2.6) |
| Massive blood loss | 1 (2.6) |
| Vascular injury | 1 (2.6) |
| Postoperative adverse event, n (%) | 17 (44.7) |
| Dysphasia/dysphonia | 1 (2.6) |
| Pneumonia | 2 (5.3) |
| Thromboembolic event | 4 (10.5) |
| Urinary tract infection | 4 (10.5) |
| Wound drainage | 4 (10.5) |
| Wound infection | 2 (5.3) |